AlphaLiquid® 100

AlphaLiquid® 100

AlphaLiquid® 100 is a test that can identify biomarkers for targeted therapy by simultaneously testing 118 cancer-related genes by drawing blood.


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
T/T
Production method
Available
Shipping / Lead Time
Negotiable / Negotiable
Keyword
ngs, liquid biopsy, cancer diagnostics, targeted therapy
Category
Medical Test Kit

IMB Dx, Inc.

Membership
PRO
Country / Year Established
South Korea South Korea / 2018
Business type
Others
Verified Certificate

1

DUNS

Product name AlphaLiquid® 100 Certification -
Category Medical Test Kit Material -
Keyword ngs , liquid biopsy , cancer diagnostics , targeted therapy Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock 32
Supply type Available HS code -

Product Information

In current clinical practice, cancer tissue biopsies are used to analyze genetic mutations. However, this approach has limitation such as side effects, costs, and difficulties in repeating the procedure multiple times. An alternative approach, liquid biopsy, analyzes genetic mutations in body fluids like blood. This method is simpler, repeatable, and can overcome the problem of tumor heterogeneity. Liquid biopsy can complement or even replace conventional tissue biopsies for clinical effectiveness. The effectiveness of liquid biopsy has been proven and there is a growing demand for it worldwide.

A test panel was created for comprehensive genome profiling consisting of 118 genes frequently observed in all solid tumors. This panel includes analysis of single nucleotide variation, insertion/deletion, and copy number alteration (42 genes), fusion (10 genes), microsatellite instability, tumor mutation burden, and mutations in homologous recombination repair gene (15 genes). This panel can be used to analyze cerebrospinal fluid, pleural effusion, ascites as well as blood in the body.

This testing can achieve an average untique molecule depth of 9,000X and provide 0.1% at 95% performance in detecting single nucleotide variation and insertions/deletions. It can also detect copy number alterations at 2.4 copies at 99%, fusion mutations at 0.2% at 95%, and microsatellite instability mutations at 1%. As a result of this performance, tissue concordance rate has been achieved at 97.6%. Additionally, results of tumor mutation burden and homologous recombination repair gene mutation analysis are provided.

B2B Trade

Price (FOB) Negotiable transportation Express
MOQ Negotiable Leadtime Negotiable
Payment Options T/T Shipping time Negotiable

IMB Dx, Inc.

Country / Year Established
South Korea South Korea / 2018
Membership
PRO
Business type
Others

1

DUNS

President
Product Category
Medical Test Kit
Year Established
2018
Main Markets

Japan Japan

Mexico Mexico

U. Kingdom U. Kingdom

U.S.A U.S.A

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more